Suneel Gupta - Chief Development Officer at Protagonist Therapeutics, Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Development Officer
Stock Symbol
PTGX on Nasdaq
All Insider Reports
All Insider Reports

Suneel Gupta - trading volume in the past year for Protagonist Therapeutics, Inc

Holdings reported by Suneel Gupta for Protagonist Therapeutics, Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 183K $5.41M $29.53 Feb 26, 2024 Direct
Stock Option (right to buy) 45K Jan 9, 2024 Direct Common Stock

Transactions reported by Suneel Gupta for Protagonist Therapeutics, Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.